PPARA and metabolic syndrome: miR-27a drives metabolic dysregulation by suppressing PPARα expression in white adipose tissue, leading to elevated free fatty acids and dyslipidemia, while PPARα activation partially reverses these alterations, highlighting its pivotal role in obesity-associated exosomal miRNA-induced glucose intolerance and lipid metabolism dysfunction (21).